The Rising Influence of Rising Affluence

[DewDiligence]

SYT posts 21% growth in 3Q11 and raises full-year guidance due to strong sales in Brazil and Argentina:

http://www.reuters.com/article/2011/10/14/syngenta-idUSL5E7LE02D20111014

This echoes what MON said on its FY4Q11 CC last week (#msg-67723695).

Biotech seeds and traits comprise only 20% of SYT’s sales (compared to 73% for MON), but this is where a large portion of SYT’s growth is expected to come from.